Ken Winkel

Dr. Ken Winkel

Australian Venom Research Unit, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Melbourne, Parkville 3010, Australia
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
TNTimo J. Nevalainen
Timo J. Nevalainen
HPHeikki J. Peuravuori
Heikki J. Peuravuori
RQRonald J Quinn
Ronald J Quinn
LLLyndon E. Llewellyn
Lyndon E. Llewellyn
JBJohn A.H. Benzie
John A.H. Benzie
Ken WinkelKen Winkel
Ken Winkel

1 November 1996 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
VKV Kronin
V Kronin
Ken WinkelKen Winkel
Ken Winkel
GSG Süss
G Süss
AKA Kelso
A Kelso
WHW Heath
W Heath
KSK Shortman
K Shortman
Previous work indicated that a subclass of mouse spleen dendritic cells (DC), those bearing CD8alpha, expresses the Fas ligand and restricts peripheral CD4 T cell responses by initiating Fas-mediated apoptosis. To determine whether a similar regulation applies to CD8 T cells, they were purified from normal or from TCR-transgenic mice, and then cultured with purified splenic CD8+ DC or CD8- DC presenting either alloantigens or the specific Ag for the TCR transgene. In all systems studied, the proliferative response of CD8 T cells was markedly less on stimulation with CD8+ DC compared with conventional CD8- DC. However, the basis of this restricted proliferation in response to CD8+ DC was totally different for CD8 T cells than for CD4 T cells. The reduced proliferation of CD8 T cells occurred later in the response than with CD4 T cells. In contrast with CD4 T cells, the reduced proliferation of CD8 T cells occurred even with T cells from Fas-deficient Ipr mice, or with DC from Fas ligand-deficient gld mice, indicating that Fas-induced apoptosis was not involved. Also, in contrast with CD4 T cells, the reduced proliferation of CD8 T cells was completely reversed by the addition of exogenous IL-2. Furthermore, cultures of CD8 T cells with CD8+ DC were found to be deficient in IL-2 production. Accordingly, although CD8+ DC are very efficient at stimulating CD8 T cells into cell division, they are deficient at stimulating endogenous cytokine production. The implications of these different DC regulatory systems are discussed.

1 December 2004 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
CHChristopher J. Hogan
Christopher J. Hogan
KBKatia Cristina Barbaro
Katia Cristina Barbaro
Ken WinkelKen Winkel
Ken Winkel

1 March 1990 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PHPaul C. Ho
Paul C. Ho
DMDavid A. Mutch
David A. Mutch
Ken WinkelKen Winkel
Ken Winkel
ASAllan Saul
Allan Saul
GJGraham L. Jones
Graham L. Jones
CRChristine M. Rzepczyk
Christine M. Rzepczyk

15 March 2001 in Blood
Verified
Journal Article
Open access
SVStéphane Vandenabeele
Stéphane Vandenabeele
HHHubertus Hochrein
Hubertus Hochrein
NMNasim Mavaddat
Nasim Mavaddat
Ken WinkelKen Winkel
Ken Winkel
KSKen Shortman
Ken Shortman
In this study, 2 distinct populations of mature dendritic cells (DCs) were identified in the human thymus. The major population is CD11b−, CD11c+, and CD45ROlowand does not express myeloid-related markers. It displays all the characteristics of mature DCs with a typical dendritic morphology, high surface levels of HLA-DR, CD40, CD83, and CD86, and expression of DC–lysosome-associated membrane glycoprotein messenger RNA (mRNA). In addition, CD11b− thymic DCs do not express macrophage inflammatory protein-1α (MIP-1α) mRNA, but express thymus-expressed chemokine (TECK) mRNA and are able to secrete bioactive interleukin 12 (IL-12) upon stimulation. In contrast, the minor and variable thymic DC population is CD11b+, CD11chigh, and CD45ROhigh and comprises CD83+CD14− mature and CD83−CD14+ immature DCs. It expresses macrophage-colony stimulating factor receptor, MIP-1α mRNA and high amounts of decysin mRNA after CD40 activation, but does not express TECK and is a weak bioactive IL-12 producer. Also identified were the IL-3Rαhigh plasmacytoid cells, which are present in the thymic cortex and medulla. Upon culture with IL-3, granulocyte/macrophage–colony stimulating factor, and CD40 ligand, the plasmacytoid cells can adopt a phenotype resembling that of freshly isolated CD11b− thymic DCs. However, these plasmacytoid-derived DCs fail to secrete bioactive IL-12; therefore, conclusions cannot be made about a direct relation between thymic plasmacytoid cells and CD11b− DCs. Whereas CD11b+ thymic DCs appear to be related to tonsillar germinal-center DCs, the major CD11b− IL-12–secreting human thymus DC population has similarities to mouse CD11b− CD8+ DCs.

1 February 1995 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
LWLi Wu
Li Wu
DVDavid Vremec
David Vremec
CACarlos Ardavin
Carlos Ardavin
Ken WinkelKen Winkel
Ken Winkel
GSGabriele Süss
Gabriele Süss
KSKen Shortman
Ken Shortman